NEURODEVELOPMENTAL OUTCOMES OF SINGLETON CONCEIVED FROM FRESH AND FROZEN EMBRYO TRANSFER COMPARED WITH NATURALLY CONCEIVED
NCT ID: NCT04772872
Last Updated: 2021-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
186 participants
OBSERVATIONAL
2021-02-01
2022-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
When mothers had been received ovarian stimulation in ART, multiple follicles and corpora lutea are produced, which produce supraphysiologic serum levels of multiple hormones and other factors, including estradiol, progesterone, and vascular endothelial growth factor (VEGF). This non physiological hormonal milieu affects both the endometrium and the embryo, potentially resulting in altered growth of the developing fetus. There was a serious effect of the supraphysiologic hormonal environment on pregnancy outcomes. (Imudia et al., 2012).
Neonates born after an IVF/ICSI procedure have an increased risk of various developmental problems, neurological disabilities, impairments or handicap, especially the cerebral palsy (CP) (Strömberg et al., 2002 and Squires and Kaplan, 2007).The increased risk of prematurity and smaller birth weight after an ART procedure required regular periodic screening and careful developmental follow-up of these children. (Boulet et al., 2008).
Singleton born after an IVF procedure were more likely to need habilitation treatment and had increased risk of developing neurological problems, especially cerebral palsy (CP), suspicion for a delay in their development. (Strömberg et al., 2002) Children born after an IVF procedure had three times higher presence of CP compared to the children from the general population and the risk of suspicion for a delay in their development was four times higher in children born after an IVF procedure than in the naturally conceived. (Strömberg et al., 2002). There is evidence of associations among the ART procedure and the developmental delay (Hvidtjørn et al., 2009).
The lack of early examination of neonates׳s neurobehavior conceived from ICSI/IVF may be led to developmental delay in these neonates. Early detection of neurobehavior deviation is essential for effective control of this potentially debilitating morbidity. As there is no available data about neurobehavior of Egyptian neonates conceived from frozen and fresh embryo transfer so there is an arising need to address this gap of knowledge.
Thus, to overcome previous limitation, the current study aimed to evaluate neurobehavior of singletons conceived from fresh and frozen embryo transfer compared with naturally conceived and screening for identify need for early intervention and developmental follow up to prevent worsening and progression of dysfunctions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A:Naturally conceived singleton
* Neonatal neurobehavior will be measured by Brazelton neonatal behavior assessment scale.
* Neonatal maturity will be represented by the variance of estimated gestational age that determined by new Ballard score.
* Apgar score will be represented by the variance of degree of scores.
* Birth weight will be measured in grams.
Assessment by Brazelton neonatal behavior for group A,Band C
* Neonatal neurobehavior will be measured by Brazelton neonatal behavior assessment scale.
* Neonatal maturity will be represented by the variance of estimated gestational age that determined by new Ballard score.
* Apgar score will be represented by the variance of degree of scores.
* Birth weight will be measured in grams.
Group B: Singleton conceived from fresh embryo transfer(IVF/ICSI)
* Neonatal neurobehavior will be measured by Brazelton neonatal behavior assessment scale.
* Neonatal maturity will be represented by the variance of estimated gestational age that determined by new Ballard score.
* Apgar score will be represented by the variance of degree of scores.
* Birth weight will be measured in grams.
Assessment by Brazelton neonatal behavior for group A,Band C
* Neonatal neurobehavior will be measured by Brazelton neonatal behavior assessment scale.
* Neonatal maturity will be represented by the variance of estimated gestational age that determined by new Ballard score.
* Apgar score will be represented by the variance of degree of scores.
* Birth weight will be measured in grams.
Group C: Singleton conceived from frozen embryo transfer (IVF/ICSI)
* Neonatal neurobehavior will be measured by Brazelton neonatal behavior assessment scale.
* Neonatal maturity will be represented by the variance of estimated gestational age that determined by new Ballard score.
* Apgar score will be represented by the variance of degree of scores.
* Birth weight will be measured in grams.
Assessment by Brazelton neonatal behavior for group A,Band C
* Neonatal neurobehavior will be measured by Brazelton neonatal behavior assessment scale.
* Neonatal maturity will be represented by the variance of estimated gestational age that determined by new Ballard score.
* Apgar score will be represented by the variance of degree of scores.
* Birth weight will be measured in grams.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment by Brazelton neonatal behavior for group A,Band C
* Neonatal neurobehavior will be measured by Brazelton neonatal behavior assessment scale.
* Neonatal maturity will be represented by the variance of estimated gestational age that determined by new Ballard score.
* Apgar score will be represented by the variance of degree of scores.
* Birth weight will be measured in grams.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton whose mothers are aged from 25 to 35 years old and has BMI ranged from 18.5 to 29.
Exclusion Criteria
1. vanishing twins (singleton birth where a twin pregnancy recorded at 7 weeks of gestational age (double heart rate at sound)).
2. Preterm singleton.
3. Congenital anomalies
4. Gestational surrogates.
5. Donor oocyte pregnant.
6. Multiple birth.
7. Singleton whose mothers have
* Metabolic diseases (hypertension and diabetes).
* Chronic health issues (asthma and epilepsy).
* Gestational condition (preeclampsia, impaired glucose tolerance, gestational diabetes, anemia and ULT occurrence).
* Placenta previa and placenta accrete.
* Premature rapture of membrane.
* Premature uterine contraction.
* Cervical insufficiency.
* Smoker mother.
1 Hour
2 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sally Ashraf Mohammed Askar
Principle investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Physical Therapy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
sally ashraf asker, assistant lecture
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sasker_phd2021
Identifier Type: -
Identifier Source: org_study_id